About Nest Pharma Private Limited
Data last updated:
Nest Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 19 March 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2009PTC063111. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹52.55 Lakh. It is led by directors including Madhukar Reddy Gujjula (Managing Director) and Vijender Reddy Kalluri.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.33 Cr, a growth of 78% compared to the previous year. For the same year it recorded a net profit of ₹35.29 Lakh (net margin 3.8%) and EBITDA of ₹48.18 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 101% over three years and 27% over five years.
The company has about 14 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Nestpharma. As per MCA filings, the company has open charges of ₹48 Lakh on record. Court records list 13 cases involving the company, including 1 filed by the company and 12 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nestpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No. 133 First Floor Mig – 133, Shivam Road Bathukammakunta, Hyderabad, Telangana, India – 500013
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nest Pharma Private Limited
The main business activity of Nest Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nest Pharma Private Limited FY 2024 filings available
Nest Pharma Private Limited reported revenue of ₹9.33 Cr (up 78% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Nest Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 78% growth in the latest year. EBITDA rose 554% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nest Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹48.18 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹35.29 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nest Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nest Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nest Pharma Private Limited
Nest Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Trichem Lifesciences Limited | ₹9.66 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Mumbai, Maharashtra, India |
| Agon Pharma Pvt Ltd | ₹9.6 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Pune, Maharashtra, India |
| Aditya Medi Pharma Private Limited | ₹9.55 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Hyderabad, Telangana, India |
| Reichindia Pharma Limited | ₹9.54 Cr (FY 2022) | •••• | •••• | -10.0% | •••• | Hyderabad, Telangana, India |
| Truelife Pharma Private Limited | ₹9.42 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Kalol, Gujarat, India |
| Nest Pharma Private Limited this company | ₹9.33 Cr (FY 2024) | •••• | •••• | 78.0% | •••• | Hyderabad, Telangana, India |
| Horster Biotek Private Limited | ₹9.25 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Indore, Madhya Pradesh, India |
| Esschem Private Limited | ₹9.23 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Mumbai, Maharashtra, India |
| Ratna Lifesciences Private Limited | ₹9.22 Cr (FY 2025) | •••• | •••• | 329.0% | •••• | Hadapsar, Pune, Maharashtra, India |
| Omkrown Pharam-Chem Private Limited | ₹9.22 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Nagar, Shahapur, Belgaum, Karnataka, India |
| Shreegen Pharma Limited | ₹9.2 Cr (FY 2023) | •••• | •••• | -32.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Nest Pharma by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nest Pharma Private Limited
Nest Pharma Private Limited is audited by RATNAKARA & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RATNAKARA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nest Pharma Private Limited
Nest Pharma has 3 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhukar Reddy Gujjula | Managing Director | 19 Mar 2009 | 17 Years 6 Months | Current |
| Vijender Reddy Kalluri Also directs: Right Remedies Association | Director | 27 Mar 2022 | 4 Years 6 Months | Current |
| Raghu J Reddy Also directs: Right Remedies Private Limited | Director | 05 Apr 2024 | 2 Years 6 Months | Current |
Ownership and Shareholding of Nest Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nest Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Apr 2014 | Bank of India | ₹48 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Nest Pharma Private Limited
Nest Pharma Private Limited has 13 court cases on record: 1 filed by Nest Pharma, 12 filed against it. All cases are disposed. Status as checked between 29 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 12 | 0 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Court case (Com.A.P.) | Filed by the company against Vistaar Financial Services Private Limited | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by Vistaar Financial Services Private Limited | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Poonawalla Fincorp Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed against the company by Tata Capital Financial Services Limited | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS CASES SS) | Filed against the company by Aditya Birla Finance Limited | Disposed |
Full case history
All 13 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Nest Pharma Private Limited
Nest Pharma operates one associated brand: Nestpharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in contract manufacturing of pharmaceutical formulations. | nestpharma.com |
Employees and EPFO Compliance at Nest Pharma Private Limited
Nest Pharma Private Limited has a workforce of 14 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Nest Pharma Private Limited
Nest Pharma has one previous CIN (Corporate Identification Number): U24233AP2009PTC063111. The current CIN is U24233TG2009PTC063111, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2009PTC063111 | Current |
| U24233AP2009PTC063111 | Previous |
Recent Activity on Nest Pharma Private Limited
Nest Pharma Private Limited has 14 board changes on record since 2009: 3 appointments and 11 cessations. The latest: Raghu J Reddy ceased to be Additional Director on 29 Sep 2024.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Nest Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nest Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nest Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nest Pharma Private Limited
Nest Pharma has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nest Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nest Pharma Private Limited
Nest Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 19 March 2009 (17+ years old) and is registered under CIN U24233TG2009PTC063111.
Nest Pharma reported revenue of ₹9.33 Cr for FY 2024 (up 78% YoY).
Nest Pharma has 3 current directors:
- Madhukar Reddy Gujjula - Managing Director
- Vijender Reddy Kalluri - Director
- Raghu J Reddy - Director
Nest Pharma reported a net profit of ₹35.29 Lakh (net margin 3.8%) and EBITDA of ₹48.18 Lakh (EBITDA margin 5.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nest Pharma is 101% over three years and 27% over five years. In the latest year (FY 2024) revenue rose 78%. CAGR is the steady yearly rate that links the first and the last year.
No. Nest Pharma has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Nest Pharma is U24233TG2009PTC063111. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nest Pharma has 13 court cases on record: 1 filed by the company and 12 filed against it.
Nest Pharma was incorporated on 19 March 2009, making it 17+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Nest Pharma by revenue are Trichem Lifesciences Limited, Agon Pharma Pvt Ltd, Aditya Medi Pharma Private Limited, Reichindia Pharma Limited, Truelife Pharma Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Raghu J Reddy ceased to be Additional Director on 29 Sep 2024. Jayasheela Reddy Nethravathi ceased to be Additional Director on 05 Apr 2024. Mandadi Abhirath Reddy ceased to be Director on 05 Apr 2024. Nest Pharma has 14 board changes on record in total.